Inventor · disambiguated record
Chandregowda Venkateshappa
Also filed as: VENKATESHAPPA CHANDREGOWDA
10 granted patents·10 pending applications·5 citations·filing 2012–2024
81Inventor score
Files withASANA BIOSCIENCES LLC5NORGINE BV3AURIGENE ONCOLOGY LTD2JUBILANT BIOSYS LTD2Jubilant Prodel LLC2
Top patents by PatentIndex Score
20 records- 0185US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 0274US12428379B2Acylsulfonamide KAT6A inhibitorsOLEMA PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·27 claims
- 0369US9371316B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 21, 2016·0 cites·18 claims
- 0469US9266873B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Feb 23, 2016·0 cites·10 claims
- 0567US2023183239A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 0665US9533981B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2013·Granted Jan 3, 2017·0 cites·21 claims
- 0762US11529341B2Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activationJubilant Prodel LLC·Filed 2019·Granted Dec 20, 2022·1 cites·15 claims
- 0860US2017073339A1Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2016·Application pending·0 cites
- 0959US9969687B2Compounds useful as CCR9 modulatorsNORGINE BV·Filed 2014·Granted May 15, 2018·1 cites·23 claims
- 1057US2025059204A1Fused benzoisoxazolyl compounds as kat6a inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1151US2024254139A1Fused isoxazolyl compounds as kat6a inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1250US2023027075A1Sulfonamide compounds targeting cd73 and adenosine receptorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 1349US9199975B2Biaryl imidazole derivatives for regulating CYP17ASANA BIOSCIENCES LLC·Filed 2012·Granted Dec 1, 2015·0 cites·18 claims
- 1449US2023027026A1Fused pyrimidine compounds, compositions and medicinal applications thereofJUBILANT BIOSYS LTD·Filed 2020·Application pending·0 cites
- 1544US2019241573A1Isoquinoline derivatives as perk inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1641US10273224B2Substituted pyrimidine compounds, compositions and medicinal applications thereofJUBILANT BIOSYS LTD·Filed 2014·Granted Apr 30, 2019·0 cites·7 claims
- 1739US2018230098A1Compounds useful as ccr9 modulatorsNORGINE BV·Filed 2018·Application pending·0 cites
- 1836US2018237441A1Chemical CompoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
- 1935US2017002011A1Benzene sulfonamides as ccr9 inhibitorsNORGINE BV·Filed 2014·Application pending·0 cites
- 2034US11629135B2Pyrimidine derivatives as inhibitors of PD1/PD-L1 activationJubilant Prodel LLC·Filed 2018·Granted Apr 18, 2023·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Chandregowda Venkateshappa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →